Navigation Links
Imaging shows some brains compensate after traumatic injury
Date:11/25/2012

CHICAGO Using a special magnetic resonance imaging (MRI) technique to image patients with mild traumatic brain injury (MTBI), researchers have identified a biomarker that may predict which patients will do well over the long term, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

The results of the study showed that in some patients the brain may have changed to compensate for the damage caused by the injury.

"This finding has huge potential implications for preventing and repairing the damage that accompanies traumatic brain injury," said Michael Lipton, M.D., Ph.D., associate director of the Gruss Magnetic Resonance Research Center at the Albert Einstein College of Medicine and medical director of MRI at the Montefiore Medical Center, Bronx, N.Y.

According to the Centers for Disease Control and Prevention, each year in the U.S. 1.7 million people sustain traumatic brain injuries. MTBI, or concussion, accounts for at least 75 percent of all traumatic brain injuries. Following a concussion, some patients experience a brief loss of consciousness. Other symptoms include headache, dizziness, memory loss, attention deficit, depression and anxiety. Some of these conditions may persist for months or even years in as many as 30 percent of patients.

Dr. Lipton and colleagues set out to determine the post-concussion symptoms and health-related quality of life for a group of patients with MTBI one year post-injury. The researchers recruited 17 patients with MTBI from the Emergency Department of Montefiore Medical Center. Within two weeks of their injury, the patients underwent diffusion tensor imaging (DTI), which measures the direction of movement of water molecules within and along axons, which comprise the bundles of nerve fibers in the brain's white matter.

"In a traumatic brain injury, it's not one specific area that is affected but multiple areas of the brain connected with axons," Dr. Lipton said.

Using DTI, the researchers measured the uniformity of water flow (called fractional anisotropy or FA) throughout the brain, pinpointing areas with low FA, which are indicative of axonal injury, and areas with abnormally high FA, as compared to healthy brains.

"Abnormally low FA within white matter has been associated with cognitive impairment in patients with TBI," Dr. Lipton said. "We believe that high FA is evidence not of axonal injury, but of brain changes that are occurring in response to the trauma."

One year after their brain injury, the patients completed two standard questionnaires to assess their post-concussion symptoms and evaluate their health status and quality of life.

Comparing the DTI data to the patient questionnaires, the researchers found that the presence of abnormally high FA was a predictor of fewer post-concussion symptoms and higher functioning. The results suggest that in patients who exhibit areas of high FA on DTI, the brain may be actively compensating for its injuries.

"These results offer us a new opportunity for treatment by finding ways to enhance the brain's compensatory mechanisms." Dr. Lipton said.


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
2. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
3. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
4. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
5. Study examines necessity of additional imaging in PET/CT oncologic reports
6. Fox Chase researchers find no disparities in imaging before breast cancer surgery
7. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
8. Mount Sinai is first in New York state to perform new Alzheimers imaging test in clinical setting
9. Imaging agents predict breast cancer response to endocrine therapy
10. Noninvasive imaging technique may help kids with heart transplants
11. Fighting obesity with thermal imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... staff members in 2017 who are passionate about making a difference in the ... and headquartered in Tampa, UMA, a nonprofit healthcare educational institution, has more than ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Sam & Associates ... to commercial and residential clients in the California Bay Area, is launching a charity ... in the region. , Heart disease is the primary killer of adult men and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a ... eastern Virginia region, is inaugurating a charity event to honor Chad Phillip Dermyer, a ... duty last year, Chad Phillip Dermyer and his fellow officers were conducting routine stops ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... St. Catherine’s ... Center. , Siena Center is a skilled nursing facility on the grounds of the ... semiprivate rooms. It recently was voted the best nursing home in Mississippi for the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... 2017 Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. ... http://www.createrealimpact.com . , Educational grants totaling $15,000 will be awarded for the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: